[1] |
Han Chengcheng, Dong Li.
Study on the Market Environment of Heparin and Development Suggestions in China Based on the PEST Model
[J]. Asian Journal of Social Pharmacy, 2025, 20(1): 38-46.
|
[2] |
Li Jingran, Zhang Dawei, Jia Zheng, Xing Hua.
Study on the Impact of Digital Economy on Innovation of Pharmaceutical Companies
[J]. Asian Journal of Social Pharmacy, 2025, 20(1): 57-67.
|
[3] |
Li Qian, Zhang Wenfeng, Yuan Hongmei.
Identification and Prediction of Key Technologies in Ginsenosides Based on Genetic Knowledge Persistence Algorithm
[J]. Asian Journal of Social Pharmacy, 2025, 20(1): 68-79.
|
[4] |
Zhang Xuefeng, Jia Zheng, Fu Shuyong, Zhang Dawei, Xing Hua.
Research on the Influence of Government R&D Funding and Enterprise R&D Investment on the Innovation Efficiency of Pharmaceutical Industry
[J]. Asian Journal of Social Pharmacy, 2024, 19(4): 361-370.
|
[5] |
Fu Nan, Li Qian, Yuan Hongmei.
Analysis of Patents Related to COVID-19 - Based on Patent Clustering Model in Specific Fields
[J]. Asian Journal of Social Pharmacy, 2024, 19(4): 371-382.
|
[6] |
Liu Baijun, Fang Tingxiu, Liu Yue, Yuan Hongmei.
Development Trend and Prediction of Stem Cell Technology in China from the Perspective of Patent
[J]. Asian Journal of Social Pharmacy, 2024, 19(3): 251-262.
|
[7] |
Ren Hongyan, Wang Yaoling, Hui Xu, Li Xue, Zhao Kun, Huang Zhe.
Meta-analysis of Cohort Studies on Clinical Efficacy of Icodextrin Peritoneal Dialysate
[J]. Asian Journal of Social Pharmacy, 2024, 19(3): 279-290.
|
[8] |
Liu Yue, Zeng Yingying, Li Xue, Yuan Hongmei.
Analysis of Technical Intelligence of Tumor Cell Therapy Based on Patent Map
[J]. Asian Journal of Social Pharmacy, 2024, 19(2): 191-201.
|
[9] |
Du Peng, Huang Zhe, Dong Li.
Game Analysis of Regulation for Online Prescription Drugs under Customer Feedback Mechanism
[J]. Asian Journal of Social Pharmacy, 2024, 19(2): 147-158.
|
[10] |
Qu Simeng, Wang Shuling.
Comparative Analysis of Profit Model of Typical Pharmaceutical O2O Enterprises in China
[J]. Asian Journal of Social Pharmacy, 2024, 19(1): 81-88.
|
[11] |
Wang Yuejun, Yang Yue, Huang Zhe.
Research on Incentive Policies for Chinese Innovative Drug R&D - Taking Innovative Anti-tumor Drugs as an Example
[J]. Asian Journal of Social Pharmacy, 2023, 18(4): 303-314.
|
[12] |
Xiu Yu, Wang Shuling.
Investigation and Countermeasures of the Development of Chinese Pharmaceutical E-commerce in the B2C Model Based on PEST-SWOT Analysis
[J]. Asian Journal of Social Pharmacy, 2023, 18(4): 398-405.
|
[13] |
Sun Quan, Zhang Fang, Dong Li.
Cost-effectiveness Analysis of Insulin Degludec and Liraglutide Injection in the Treatment of Type 2 Diabetes
[J]. Asian Journal of Social Pharmacy, 2023, 18(3): 281-295.
|
[14] |
Li Qiao, Wang Aili, Wu Di, Chen Yuwen.
Analysis of Adverse Reactions in the Treatment of COVID-19 with Three Chinese Patent Medicines and Three Herbal Formulas
[J]. Asian Journal of Social Pharmacy, 2023, 18(1): 8-16.
|
[15] |
Chen Chuhan, Sun Lihua.
Economic Evaluation of Cervical Cancer Prevention Strategies in China
[J]. Asian Journal of Social Pharmacy, 2023, 18(1): 57-63.
|